Cargando…
Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson’s Disease
Parkinson’s disease is a neurodegenerative disease affecting mainly the elderly population. It is characterized by the loss of dopaminergic neurons of the substantia nigra pars compacta region. Parkinson’s disease patients exhibit motor symptoms like tremors, rigidity, bradykinesia/hypokinesia, and...
Autores principales: | Siddiqui, Talha, Bhatt, Lokesh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231286/ https://www.ncbi.nlm.nih.gov/pubmed/37259012 http://dx.doi.org/10.1007/s11064-023-03960-6 |
Ejemplares similares
-
Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014) -
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
por: Malar, Dicson S., et al.
Publicado: (2023) -
Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
por: Fakhri, Sajad, et al.
Publicado: (2021) -
Promising drug targets and associated therapeutic interventions in Parkinson’s disease
por: Rai, Sachchida Nand, et al.
Publicado: (2021) -
The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
por: Wang, Tao, et al.
Publicado: (2023)